Hesse demands correction: Cannabis legalization was as bad as the heating law
Hesse's government is calling for a revision of cannabis legalization laws, comparing their impact to that of the government's heating law, highlighting internal political conflicts.
The government of Hesse, led by Interior Minister Roman Poseck from the CDU party, is pushing for revisions to the recently established cannabis legalization laws, stating that the implications of this legislation are comparable to the controversial heating law. This assertion reflects broader political tensions within Germany, particularly between the CDU and its coalition partner, the SPD, which is blocking efforts to repeal the cannabis law despite promises made by the CDU before the Bundestag elections. As the CDU seeks to appeal to its base by advocating for a scrapping of the law, the SPD's resistance poses a significant barrier to these ambitions.
The cannabis legalization law in question was met with considerable opposition from various experts and parties during its formulation, with the CDU openly criticizing the decision-making process that led to its enactment. The CDU had pledged to dismantle these laws if they regained control in the government, but their current coalition agreement permits only a review of the law's outcomes rather than an outright repeal. The initial findings from this review, presented last fall, have been described as lacking robustness, raising questions about the effectiveness of the legislation and the government's willingness to reconsider it.
Furthermore, this situation illustrates the ongoing challenges within the current coalition government as they grapple with diverging interests and pressures from both the public and expert communities. The call from Hesse's officials for corrective measures underlines a broader struggle over cannabis policy in Germany, reflecting concerns over public health, safety, and governance that may continue to evolve as political debates progress. The outcome of these discussions will likely impact future drug policies in Germany and the effectiveness of the current coalition framework.